Navigation Links
Bauer Calls Taxpayer-Funded Embryonic Stem Cell Research 'A Tragedy'
Date:3/9/2009

WASHINGTON, March 9 /PRNewswire-USNewswire/ -- Former Presidential candidate Gary Bauer on Monday called Barack Obama's decision to waste federal tax dollars on failed embryonic stem cell research "evidence that ideology is the goal here, not saving lives. We are witnessing the beginnings of a tragedy, as lives will be lost and not saved as a result of this change."

The president of American Values made the following statement: "It's tragic that Barack Obama is willing to take tax money from struggling Americans and give it to scientists working on repeatedly failed embryonic stem cell projects...especially as adult stem cell research is yielding real, life-saving results. Most people do not understand that there is no restriction against fetal stem cell research, just a restriction against spending tax dollars to destroy human embryos for a body of work that has resulted in cancers and abnormal cells time and time again. Adult stem cell research, on the other hand, has provided real hope to many patients. In 2008, the National Institutes of Health spent nearly one billion dollars on stem cell research, most of it going to adult stem cell research because of the real hope it offered.

"This policy shift is part of an anti-life agenda that now will allow human embryos to be destroyed to create cell lines. My concern is that the long-term result of this work will lead to a lifting of the ban against human cloning, a development that would allow testing in laboratories on human embryos, human life. But today, Obama's decision to allow federal tax dollars to be used to destroy human embryos is tragic on many levels. He raises false hope for those who are ill; he strains the American taxpayer at a time of economic crisis, and he ignores the humanity of the lives ended in cold laboratories to satisfy a liberal ideology."


'/>"/>
SOURCE American Values
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. CFSO Calls for Roundtable to Develop National Strategy for Advancing Forensic Sciences in the United States
2. China Bio-Immunity Corporation Initiates Voluntary Recalls of Rabies Vaccines
3. Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees
4. Kaiser Permanente CEO Calls for Connected Health Care
5. International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive
6. ETHEX Corporation Voluntarily Recalls Specific Lots of 30 mg. and 60 mg. Morphine Sulfate Extended Release Tablets Due to the Potential for Oversized Tablets
7. World Hepatitis Alliance Calls on Governments to Take Urgent Action to Tackle Chronic Viral Hepatitis B & C Epidemic
8. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
9. Frost & Sullivans Biopharmaceuticals Market Briefing to Address the Use of Embryonic Stem Cells
10. ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells
11. MultiVu Video Feed: Geron Receives FDA Clearance to Begin Worlds First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ProMIS Neurosciences (“ProMIS” or the ... diseases, today announced it has issued a scientific white paper entitled “Results from ... series of commentaries from ProMIS’s scientific team offering insight into the Company’s product ...
(Date:2/22/2017)... Origin (Origin Agritech, LLC, a subsidiary of Origin Agritech ... Arcadia (Arcadia Biosciences, Inc., NASDAQ: RKDA), a ... productivity traits and nutritional products, today announced their collaboration to achieve ... China to the United States ... ...
(Date:2/22/2017)... and SAN DIEGO , Feb. ... "Company") (OTCQB:CELZ) announced today expansion of its translational ... cell product through establishment of laboratory facilities in ... at the San Diego BioLabs facility, a biotechnology ... Novartis, and Sanofi. In November 2016, ...
(Date:2/21/2017)... ... February 21, 2017 , ... During HIMSS 2017, ... health applications, announced a partnership with Redox, a leader in cloud-based healthcare integration ... clinical systems while keeping data secure in the cloud. , The digital health ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):